ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Don’t Let Diabetes Shortchange Your Golden Years

By: NewsUSA

(NewsUSA) - Dianne Mattiace shows that managing diabetes shouldn’t get in the way of enjoying your retirement, thanks in part to a game changing new technology

After a busy career in healthcare, Dianne has finally retired with her husband in Alabama. However, she has no intention of slowing down. Dianne is looking to live life to its fullest, whether that’s serving on the Board of a local charity, spending time with her grandchildren or swimming in the lake by her house in summer.

Now in her early seventies, Dianne was first diagnosed with type 1 diabetes over 30 years ago and spent many years adjusting to the stress of managing her diabetes. At times she felt like she had lost control of her diabetes and her life.

On one occasion, while her husband was traveling for work, Dianne was hospitalized in Florida on the edge of diabetic ketoacidosis, a potentially life-threatening complication. “It was quite scary for me and my family. Thankfully I was treated successfully, but adapting to life with diabetes was proving very difficult for me. It was taking a significant toll on my physical and mental health”, Dianne reflects.  

It was during one of these tough periods where Dianne’s endocrinologist suggested that she try something completely new. Like many people living with diabetes, Dianne was using a continuous glucose monitor (CGM), but found traditional models to be uncomfortable, cumbersome and restrictive. Ultimately, they had presented challenges for her active life. That’s when Dianne became the first ever person to be prescribed an Eversense CGM in 2018.

" "Dianne had never heard of Eversense, until her endocrinologist introduced it as a unique CGM option that could perfectly suit her lifestyle. Currently on her 24th Eversense system, she has never looked back.  

Eversense is the world’s first and only fully implantable and long-term CGM. The latest version, Eversense E3 lasts an astonishing 180 days, compared to just 7-14 days for other available CGMs. “It’s such a relief not to worry about constantly replacing sensors, booking doctor’s appointments and carrying endless supplies,” Dianne says.

A sensor is inserted under the skin in the upper arm by a trained health care provider, and then one is free to go for a whole six months. With only two replacements needed a year, a removable smart transmitter1 is worn over the sensor and seamlessly sends glucose readings directly to a smartphone.

Although Dianne did not consider herself tech-savvy, she quickly adapted to life with Eversense and immediately saw the benefits. The user-friendly app has helped simplify her decision making and she feels as though she can trust her CGM’s glucose readings due to Eversense’s exceptional accuracy.

“If I had to pick one feature that I love the most, it would be the subtle on-body vibratory alerts,” Dianne added. “Eversense discretely lets me know if my glucose levels need attention, without attracting the attention of others. It’s perfect for when I’m at church or catching a movie, when I don’t want a phone making a lot of noise. It also means I can be away from my phone from time to time and live in the moment.”

All in all, Eversense has allowed Dianne to enjoy her retirement without spending every moment worrying about her diabetes. “I don’t let diabetes control me,” she says, “It’s never too late to embrace something new and change your habits, especially when it comes to diabetes care.”

The Eversense E3 CGM, brought to people by Ascensia Diabetes Care, has been called the “CGM for real life” and Dianne couldn’t agree more. The ability to remove and replace the Eversense transmitter[1] means that Dianne no longer worries about taking a swim in the lake or knocking off her CGM when playing with her grandchildren.

Dianne’s liberating experience with the Eversense E3 is becoming an often-repeated story, as more users discover the ease, convenience and freedom of the Eversense E3. People with diabetes, regardless of age, can appreciate all of the benefits that this unique product can offer, Dianne says.

The Eversense E3 has recently received expanded Medicare coverage, making it even more accessible for many people living with diabetes across the US.

For more information about successfully managing diabetes, visit EversenseDiabetes.com/get-started-today.

 

[1] There is no glucose data generated when the Eversense E3 transmitter is removed. For an overview of Eversense CGM safety information, please visit www.eversensediabetes.com/safety-info. Please visit www.ascensiadiabetes.com/eversense for limitations, restrictions, references and copyright information.

Recent Quotes

View More
Symbol Price Change (%)
AMZN  249.32
-4.68 (-1.84%)
AAPL  270.04
+0.99 (0.37%)
AMD  250.05
-9.60 (-3.70%)
BAC  53.54
-0.02 (-0.04%)
GOOG  278.06
-6.06 (-2.13%)
META  627.32
-10.39 (-1.63%)
MSFT  514.33
-2.70 (-0.52%)
NVDA  198.69
-8.19 (-3.96%)
ORCL  248.17
-9.68 (-3.75%)
TSLA  444.26
-24.11 (-5.15%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.